About one in eight women will develop invasive breast cancer over the course of her lifetime. Causes can be the use of synthetic sex hormones and other environmental factors, but also gene mutations like in the BRCA1 gene ...
May 31, 2016
0
17
In colorectal cancer, the presence of invasive tumor cells at the advancing edge of the tumor can provide valuable information on prognosis. Initiated by the Colorectal Cancer Research Group at the Institute of Pathology, ...
May 31, 2016
0
4
A model developed to estimate the absolute risk of breast cancer suggests that a 30-year-old white woman in the United States has an 11.3 percent risk, on average, of developing invasive breast cancer by the age of 80, according ...
May 26, 2016
0
35
Adding biological markers of risk to breast cancer risk prediction models currently in use in the clinic appears to improve risk prediction, especially for postmenopausal women not using hormone therapy (HT), according to ...
Apr 19, 2016
0
13
(HealthDay)—The risk of colorectal cancer is increased after a diagnosis of prostate cancer, according to a study published online Feb. 25 in Cancer.
Mar 1, 2016
0
9
MIPT scientists together with their colleagues from St. Petersburg and Israel have analyzed more than 500 previously published scientific articles and proposed their own approach to the choice of methods used for the treatment ...
Feb 10, 2016
0
2
Documenting that it's never too late to quit smoking, a large study of breast cancer survivors has found that those who quit smoking after their diagnosis had a 33 percent lower risk of death as a result of breast cancer ...
Jan 26, 2016
2
14
(HealthDay)—A redesigned Olympus TJF-Q180V duodenoscope (a type of endoscope) that has a reduced chance of spreading infection has been approved by the U.S. Food and Drug Administration.
Jan 18, 2016
0
0
(HealthDay)—BRCA1/2 mutation carriers have increased risk of contralateral breast cancer (CBC), with age at first diagnosis a significant predictor of CBC risk, according to a study published online Dec. 23 in the Journal ...
Dec 30, 2015
0
37
Compared with receiving chemotherapy alone, women with breast cancer who also received the hormonal drug triptorelin to achieve ovarian suppression had a higher long-term probability of ovarian function recovery, without ...
Dec 22, 2015
0
2
